Evelyn V. Moreno’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-25,161
| Closed | -$1.76M | – | 142 |
|
|
2023
Q3 | $1.76M | Sell |
25,161
-26,911
| -52% | -$1.91M | 0.38% | 58 |
|
|
2023
Q2 | $3.6M | Sell |
52,072
-9,488
| -15% | -$675K | 0.77% | 47 |
|
|
2023
Q1 | $4.57M | Buy |
61,560
+379
| +0.6% | +$31.8K | 1.04% | 40 |
|
|
2022
Q4 | $5.7M | Buy |
61,181
+29,587
| +94% | +$2.85M | 1.32% | 28 |
|
|
2022
Q3 | $3.01M | Sell |
31,594
-40,647
| -56% | -$4.02M | 1.36% | 17 |
|
|
2022
Q2 | $6.69M | Sell |
72,241
-27,654
| -28% | -$2.7M | 1.56% | 20 |
|
|
2022
Q1 | $10.1M | Sell |
99,895
-5,140
| -5% | -$540K | 2.05% | 13 |
|
|
2021
Q4 | $10.8M | Buy |
105,035
+5,055
| +5% | +$467K | 2.17% | 13 |
|
|
2021
Q3 | $8.48M | Sell |
99,980
-4,085
| -4% | -$342K | 2% | 18 |
|
|
2021
Q2 | $8.68M | Buy |
104,065
+19,777
| +23% | +$1.62M | 2.04% | 19 |
|
|
2021
Q1 | $6.34M | Sell |
84,288
-270
| -0.3% | -$19.7K | 1.51% | 35 |
|
|
2020
Q4 | $5.78M | Sell |
84,558
-1,980
| -2% | -$129K | 1.43% | 34 |
|
|
2020
Q3 | $5.05M | Buy |
86,538
+605
| +0.7% | +$37.6K | 1.37% | 33 |
|
|
2020
Q2 | $5.58M | Buy |
85,933
+50
| +0.1% | +$3.15K | 1.62% | 30 |
|
|
2020
Q1 | $5.09M | Buy |
85,883
+1,357
| +2% | +$90.6K | 1.73% | 27 |
|
|
2019
Q4 | $6.28M | Sell |
84,526
-23,331
| -22% | -$1.64M | 1.69% | 31 |
|
|
2019
Q3 | $6.8M | Buy |
107,857
+2,444
| +2% | +$145K | 1.87% | 28 |
|
|
2019
Q2 | $5.74M | Sell |
105,413
-4,469
| -4% | -$241K | 1.75% | 32 |
|
|
2019
Q1 | $5.93M | Buy |
109,882
+240
| +0.2% | +$14.8K | 1.75% | 29 |
|
|
2018
Q4 | $7.18M | Sell |
109,642
-1,816
| -2% | -$136K | 2.37% | 15 |
|
|
2018
Q3 | $8.77M | Sell |
111,458
-4,023
| -3% | -$288K | 2.46% | 12 |
|
|
2018
Q2 | $7.43M | Buy |
115,481
+23,200
| +25% | +$1.53M | 2.17% | 15 |
|
|
2018
Q1 | $5.74M | Buy |
92,281
+600
| +0.7% | +$43K | 1.76% | 29 |
|
|
2017
Q4 | $6.65M | Sell |
91,681
-4,375
| -5% | -$318K | 2.01% | 24 |
|
|
2017
Q3 | $7.81M | Buy |
96,056
+1,625
| +2% | +$129K | 2.34% | 14 |
|
|
2017
Q2 | $7.6M | Sell |
94,431
-556
| -0.6% | -$43.9K | 2.33% | 14 |
|
|
2017
Q1 | $7.46M | Buy |
94,987
+12,835
| +16% | +$1.02M | 2.27% | 14 |
|
|
2016
Q4 | $6.48M | Buy |
82,152
+11,955
| +17% | +$967K | 2.34% | 15 |
|
|
2016
Q3 | $6.25M | Buy |
70,197
+515
| +0.7% | +$48.6K | 2.29% | 10 |
|
|
2016
Q2 | $6.67M | Buy |
69,682
+5,700
| +9% | +$568K | 2.53% | 6 |
|
|
2016
Q1 | $6.64M | Buy |
63,982
+705
| +1% | +$68.6K | 2.57% | 4 |
|
|
2015
Q4 | $6.19M | Buy |
63,277
+125
| +0.2% | +$12.2K | 2.58% | 4 |
|
|
2015
Q3 | $6.09M | Buy |
63,152
+260
| +0.4% | +$27.3K | 2.62% | 5 |
|
|
2015
Q2 | $6.6M | Sell |
62,892
-6,368
| -9% | -$651K | 2.62% | 5 |
|
|
2015
Q1 | $7.15M | Sell |
69,260
-1,344
| -2% | -$136K | 2.7% | 5 |
|
|
2014
Q4 | $6.8M | Buy |
70,604
+349
| +0.5% | +$30.8K | 2.5% | 4 |
|
|
2014
Q3 | $5.59M | Buy |
70,255
+781
| +1% | +$61.6K | 2.15% | 8 |
|
|
2014
Q2 | $5.24M | Buy |
69,474
+1,485
| +2% | +$112K | 1.97% | 13 |
|
|
2014
Q1 | $5.09M | Buy |
67,989
+80
| +0.1% | +$5.65K | 2% | 10 |
|
|
2013
Q4 | $4.86M | Buy |
+67,909
| New | +$4.36M | 2.01% | 11 |
|
Other funds holding CVS
Evelyn V. Moreno's CVS Position: Q4 2023 in Review
Evelyn V. Moreno sold out of CVS Health (CVS) in Q4 2023, closing a stake of 25,161 shares — an estimated $1.76M sold.
Evelyn V. Moreno first reported a position in CVS in Q4 2013 and held it in 40 quarters. The position peaked at $10.8M in Q4 2021. 2,257 funds tracked by Wall St. Rank hold CVS as of Q4 2023.
- Evelyn V. Moreno reported no remaining CVS Health position as of Q4 2023 after selling out during the quarter.
- Evelyn V. Moreno sold 25,161 CVS Health shares in Q4 2023, an estimated $1.76M.
- Evelyn V. Moreno first reported a position in CVS Health in Q4 2013 and held it in 40 quarters.
- Evelyn V. Moreno's CVS Health position peaked at $10.8M in Q4 2021.
- 2,257 funds tracked by Wall St. Rank held CVS Health as of Q4 2023.
Based on Evelyn V. Moreno's 13F filing for Q4 2023, filed 9 Feb 2024.